# The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension

> **NCT05521282** · PHASE4 · COMPLETED · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 269 (actual)

## Conditions studied

- Hypertension
- Medicine, Chinese Traditional

## Interventions

- **DRUG:** Treatment group

## Key facts

- **NCT ID:** NCT05521282
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-09
- **Primary completion:** 2022-06-03
- **Final completion:** 2022-06-30
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2022-08-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05521282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05521282, "The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05521282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*